"Slight green. a $2m/year contract is not price sensitive. not anymore ,and not for a ~$9bn company"
Mr Market begs to differ. PME is up 1.8% as I write and the market is down 0.9%.
But more important than any daily fluctuation, is the that wining another contract with an IDN (Integrated Delivery Network) increases the confidence about the size of the PME's addressable market. PME has had great success with the premier institutions, but analysts like Gold in Sacks fretted that they couldn't sell to the down and dirty for-profit health providers. Every win of any size in that category is further confirmation that PME is on course to become the Microsoft of radiology software. Indeed, a small contract win with an IDN is just as significant as any other in that respect as confirmation of the extent of PME's addressable market.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)